MENU
IMA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ImageneBio (IMA) Ownership - Who owns ImageneBio?

ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
65.41M
P/E Ratio
N/A
Total Cash
142.58M
Projected Growth
N/A
Total Debt
3.45M
Revenue
800K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
12.75
Total Debt/Equity
N/A
Revenue/Share
0.07 USD as % of share price

Fundamentals

IMA
Capitalization
65.4M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
143M
Total Cash/Share
12.75
Total Debt
3.45M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.07%
Revenue
800K
ROE
N/A
Book Value
140M
P/B Ratio
0.47
Cash Flow
N/A
Earnings
-4.77
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11K
Current Ratio
13.24
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-45.52M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-33.17
Shares Held By Institutions
39.9M
Shares Outstanding - Current
11.2M
Total Liabilities
21M
Total Volume MTD
N/A
Value
1
Gain YTD
256.707
View a ticker or compare two or three
IMA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details